Generics Industry News Search
 |
|
|
|
|
|
|
May 2015 News Archive |
|
|
| |
|
Teva today announced a voluntary recall of eight lots of Adrucil (Fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) due to the potential presence of particulate matter identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announced the launch of two new strengths of Clozapine ODT (orally disintegrating tablets), the generic version of Jazz Pharmaceutical's FazaClo...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Vanc is pleased to announce that is has received DINs from Health Canada for 5 new generic molecules as an initial notice of consent for new drug submissions...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark has been granted tentative approval by the FDA for Calcipotriene cream 0.005 %, the therapeutic equivalent of Dovonex topical cream of Leo...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced the US launch of Levonorgestrel and Ethinyl estradiol tablets USP, 0.15 mg/0.03 mg, which is the generic version of Teva's Seasonale tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today confirmed that it has been sued by Noven and Hisamitsu, in connection with the filing of an ANDA with the FDA for Estradiol transdermal system...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A unit of GlaxoSmithKline, the UK's largest drugmaker, joined with Canadian business partner Apotex, to sue Indian generic pharmaceutical firm Lupin over plans to market copies of the antidepressant Paxil...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today announced that it will immediately re-launch its generic version of AstraZeneca's Pulmicort respules (Budesonide inhalation suspension) 0.25 and 0.5 mg vials following a decision from the United States Court of Appeals...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan, a global pharmaceutical company, have been sued by Noven and Hisamitsu in connection with the filing of an ANDA with the FDA for Estradiol transdermal system, USP, twice-weekly 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A US Appeals Court has temporarily blocked the sale of Novartis' Zarxio, a biosimilar version of Amgen's Neupogen, until a legal battle between the companies is settled...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Japan's Eisai will begin importing ingredients from India in order to create high-quality generic drugs cheaply...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Horizon, today announced that its affiliates have entered into a settlement and license agreement with Perrigo, to resolve pending patent litigation involving Pennsaid (Diclofenac sodium topical solution) 2 %w/w (Pendsaid 2 %)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Epirus Biopharmaceuticals, and mAbxience, a biopharmaceutical company specialised in research, development and manufacturing of biosimilars, entered into a development and future distribution deal for Epirus' lead program...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
In a relief to US pharm major Merck Sharp and Dohme, the Supreme Court today restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A US class action lawsuit accusing India's Ranbaxy of large-scale deception on its generic drug applications puts a question mark on drug imports from India, the largest supplier of generic drugs to the US...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announced the launch of Risedronate sodium delayed-release tablets, the generic version of Warner Chilcott's Atelvia...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Neos Therapeutics today announced that the U.S. FDA has provisionally accepted the trade name Cotempla XR-ODT for its Methylphenidate extended-release orally disintegrating tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Neos, a company with three late-stage extended-release (XR) product candidates for the treatment of ADHD currently in development, today announced that the FDA has provisionally accepted the trade name Cotempla XR-ODT for its methylphenidate extended-release orally disintegrating tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A US group is trying to block patents in five countries for Gilead costly hepatitis C drug Sovaldi, in a bid to give almost 60 million afflicted people access to cheaper generic versions...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark Pharmaceuticals today said it has been granted tentative approval by the US health regulator to sell Rufinamide, which is used to treat seizures caused by Lennox-Gastaut syndrome...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
HIV/Aids patients and civic groups yesterday demanded the government not approve a private drug giant's request for a hepatitis C drug patent in Thailand...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Actavis today confirmed that a panel of the U.S. Court of Appeals for the Second Circuit has issued a ruling upholding a December 15, 2014 preliminary injunction requiring the company to continue distribution of Namenda (Memantine HCl) immediate-release tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Par today announced that the United States Court of Appeals for the Federal Circuit has upheld the U.S. District Court for the District of Delaware's earlier ruling that Par's filing of an ANDA for its generic version of Novartis' Exelon patch (Rivastigmine transdermal system) does not infringe United States Patent Nos. 6,316,023 or 6,335,031...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
India's Aurobindo has submitted an ANDA for Dolutegravir 50 mg, for tentative approval to the FDA, for the treatment of HIV....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Novo Nordisk on Wednesday rejected claims by Baxter that its drug used substances developed by the US rival, following the launch this week of a US investigation into possible patent infringement...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Amarin announced today that Judge Randolph D. Moss of the federal district court for the District of Columbia has granted Amarin's motion for summary judgment in the company's lawsuit against the FDA seeking an order requiring FDA to recognize five-year, NCE, marketing exclusivity for Vascepa (Icosapent ethyl) capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
IGI, a New Jersey based specialty generic pharmaceutical company, today announced it has submitted its third ANDA to the FDA of 2015, which brings the Company's total number of ANDA submissions now pending at the FDA to twenty-five....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announces the launch of the generic equivalent of Lomedia 24 Fe (Norethindrone acetate and Ethinyl Estradiol tablets USP...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark today said it has received the final approval from US health regulator for its generic version of Desmopressin acetate tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
